HBV (DBCOND0040214)

Identifiers

Synonyms
Hepatitis B virus / Hepatitis B virus (HBV) / Hepatitis B virus test

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT02836236
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B (China)treatment3completed
NCT06372990
Rapid T-cell Analysis Test in Patients With Chronic HBV and HBV/HDV DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT03625102
A Randomized, Double-Blind Trial of Antroquinonol in Patients With Chronic Hepatitis Btreatment2completed
NCT01970254
Widespread vs. Selective Screening for Hepatitis B Infection Prior to ChemotherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT04562051
Stratified vs Routine Prophylaxis in Living Kidney Transplantation From HBsAg+ Donors to HBsAg- RecipientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT05951751
The TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM)No drug interventionshealth_services_researchNot Availablerecruiting
NCT03239353
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Entecavir Extended Release (XR) in Healthy Subjectstreatment1completed
NCT04286347
HCV, HBV, HIV Testing During Consultation With AnesthesiologistNo drug interventionsdiagnosticNot Availableterminated
NCT04059198
Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virustreatment2terminated
NCT05597800
Nivolumab/Ipilimumab and Chemotherapy Combination in Advanced NSCLC Patients With HIV, HBV, HCV and Long Covid Syndrometreatment2not_yet_recruiting
NCT05786859
The Efficacy and Safety of Rifaximin Treatmenttreatment0recruiting
NCT04886336
The Impact of Tenofovir Alafenamide on Profiles of Body Weight and Metabolic Features in Chronic Hepatitis B Patients.No drug interventionsNot AvailableNot Availableunknown_status
NCT04539119
Entecavir and Tenofovir Versus Entecavir in Lymphoma Patients With Positive HBV DNAtreatment3unknown_status
NCT04683341
Tenofovir Alafenamide in HBV Related Decompensated Livertreatment4recruiting
NCT01438424
Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir Trialstreatment2completed
NCT06503796
Antiviral Therapy in Infants With HBV Infectiontreatment4not_yet_recruiting
NCT04904835
Access HBV Assays - European Union (EU) Clinical Trial Protocol -No drug interventionsNot AvailableNot Availablerecruiting
NCT05028322
Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine Regimenprevention2not_yet_recruiting
NCT04703465
Tenofovir Alafenamide for HBV Prophylaxis in HBV(-) Liver Transplant Recipients With HBcAb+ DonorspreventionNot Availableunknown_status
NCT02071082
Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected Adultstreatment3completed
NCT02312531
Prevention for Mother-to-infant Transmission of HBVpreventionNot Availablecompleted
NCT02344680
Liver Fibrosis in Zambian HIV-HBV Co-infected PatientsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05001672
The Efficacy of Prophylactic TAF for HBsAg-positive Patients Receiving bDMARDsprevention4not_yet_recruiting
NCT02044068
Hepatitis B Virus Vertical Transmission From HIV-HBV Co-infected WomenNo drug interventionsNot AvailableNot Availablecompleted
NCT05781568
Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC)No drug interventionsNot AvailableNot Availablerecruiting
NCT03753308
Mechanism of DCs Dysfunction in Chronic HBV InfectionNo drug interventionsNot AvailableNot Availableunknown_status
NCT02454764
'Tenofovir Pulse and Peg Interferon Alpha 2b' Therapy in HBeAg-positive Patients With Normal ALTtreatmentNot Availablewithdrawn
NCT04023721
Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitortreatment2terminated
NCT00678587
Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedurestreatment3terminated
NCT05063071
Tenofovir Alafenamide for HBV Prophylaxis in Post Orthotopic Liver Transplanttreatment4unknown_status
NCT05965388
Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral TherapyNot AvailableNot Availablenot_yet_recruiting
NCT01556815
Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular CarcinomaNo drug interventionstreatment2unknown_status
NCT04054037
A Study of AARC Standards on Diagnosis and Treatment of Patients With HBV-ACLF in China (AARC China Study)No drug interventionsNot AvailableNot Availableunknown_status
NCT05442437
Clinical Study of hUC-MSCs Treating Decompensated Liver Cirrhosis With HBVtreatment0completed
NCT05181332
Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With CirrhosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT03193775
Impact of Hepatitis B Vaccination on HBs AntigenemiatreatmentNot Availablecompleted
NCT02836249
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B (China)treatment3completed
NCT03932513
Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B Patientstreatment2terminated
NCT06579313
Current Situation of Health Care in Women With HBV or HCV InfectionNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03158818
Chronic Hepatitis B Virus Infection in ZambiaNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02826018
A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) InfectionNo drug interventionstreatment1terminated
NCT01590641
A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis Btreatment1completed
NCT05677724
Single-cell RNA Sequencing Resolves the Regulatory Role of HBV on the Hepatocellular Carcinoma Immune MicroenvironmentNo drug interventionsNot AvailableNot Availablerecruiting
NCT05293158
Impact of Hepatitis B Immunoglobulins in Patients With Chronic Hepatitis B on Hepatocellular Carcinoma - a Proof of Concept StudytreatmentNot Availablenot_yet_recruiting
NCT05125458
Relationships Among Inflammation, Physical and Mental Health in Subjects With Chronic Inflammatory Physical Diseases.No drug interventionsNot AvailableNot Availablecompleted
NCT04942886
Prophylactic Entecavir for HBV Reactivation in Past HBV Infected Patients With Hematopoietic Stem Cell TransplantationtreatmentNot Availableenrolling_by_invitation
NCT02658786
Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablewithdrawn
NCT02434848
A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Coursesprevention2 / 3completed
NCT04568265
A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis Btreatment2recruiting
NCT03149627
Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian AdultsNo drug interventionsNot AvailableNot Availablecompleted
NCT02039362
Prevention of Hepatitis B Virus Vertical Transmission by Serovaccination and Tenofovir During Pregnancyprevention4completed
NCT01637844
Telbivudine Therapy in HBeAg-positive Pregnant Women to Prevent Mother-to-infant Transmission of HBVprevention4completed
NCT04034368
A Perspective Study of the Antiviral Efficacy and Safety of Switching to TAF Treatment in CHB Adults With Suboptimal Response (SOR) and Intolerant to Entecavirtreatment4unknown_status
NCT04519710
Specific Anti-HBV Vaccine Response After Vaccination in Patients Requiring Anti-CD20 Monoclonal AntibodiestreatmentNot Availablecompleted
NCT06307808
Viral Immunity in Solid Organ Transplant Recipients: Monitoring Of The Response To Hepatitis B Booster VaccinationNot AvailableNot Availablenot_yet_recruiting
NCT02086708
Ultrasound Method to Measure Fibrosis of the Liver in ChildrenNo drug interventionsdiagnosticNot Availableterminated